CLPT Q4 2023 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$340M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M+31.6% YoY

Gross Profit

$4M58.9% margin

Operating Income

-$5M-69.1% margin

Net Income

-$5M-67.8% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+18.2%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$43M

Total Liabilities

$21M

Stockholders' Equity

$21M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+31.6%
Gross Profit	$4M	$3M	+21.0%
Operating Income	-$5M	-$4M	-5.3%
Net Income	-$5M	-$4M	-5.3%

Revenue Segments

Functional Neurosurgery Navigation and Therapy

$2M50%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M50%

Functional Neurosurgery Navigation and Therapy - Services

$1,0000%